Placebo-Driven Clinical Trials of Transfer Point Glucan #300 in Children with Chronic Respiratory Problems: III. Clinical Findings
Vetvicka Vaclav1, Richter Josef2, Svozil Vladimir2, Rajnohova Dobiasova Lucie2 & Kral Vlastimil2 Show affiliations
- University of Louisville, United States
- Regional Institute of Public Health, Ústí nad Labem, Czech Republic
American Journal of Immunology, Volume 9, Issue 3, pp. 88–93 · doi.org/10.3844/ajisp.2013.88.93
Abstract
The role of glucan in stimulation of immune reactions has been studied for decades. In this report we focused on the effects of orally administered glucan in children with chronic respiratory problems. We measured the physical endurance using a 6MWT test and the levels of eNO in 50 children aged 8-12 years and evaluated the effects of 100 mg/d oral dose of glucan. We found significant improvements in physical indurance and exhaled nitric oxide in glucan-treated children. In addition, strong improvements in general conditions were found. Short-term oral application of natural immunomodulator β-glucan enhancers the overall health and regulation of energetic metabolism in children with chronic respiratory problems.
Licence and reuse
Free to read. This article carries the publisher’s copyright, as printed on it: © 2013 Science Publications. It is free to read; ask us before reusing it.
How to reuse this articleResponses (0)
About this article
Vaclav, V., Josef, R., Vladimir, S., Lucie, R. D. & Vlastimil, K. (2013). Placebo-Driven Clinical Trials of Transfer Point Glucan #300 in Children with Chronic Respiratory Problems: III. Clinical Findings. American Journal of Immunology, 9(3), 88–93. https://doi.org/10.3844/ajisp.2013.88.93
- Licence
- © Science Publications
- Issue
- Volume 9, Issue 3
- Policies
- Editorial independenceUse of generative AIData availabilityAppeals and complaints
- Version
- Version of record